Mp76-10 transurethral Ultrasound Ablation (Tulsa) for Benign Prostatic Obstruction: 12 Months Clinical Outcomes

Abstract

with a baseline score of <9. Mean difference , p[0.002. Patients with a baseline MSHQ function score of !9 had a significantly greater decrease in 24-month MSHQ function score compared to patients with a baseline score of<9. Mean difference , p[0.009. Change in IIEF function are stratified by the median (<54 vs. !54). Patients with a baseline MSHQ function score of !54 had a significantly greater decrease in 24-month MSHQ function score compared to patients with a baseline score of <54. Mean difference[-13.36 (95% CI: -21.04, -6.27), p<0.001. Patients with a baseline MSHQ function score of !54 had a greater decrease in 24 months MSHQ function score compared to patients with a baseline score of <54, though the difference was not statistically significant. Mean difference[-7.94 (95% CI: -16.59, 0.70), p[0.07 CONCLUSIONS: In this cohort of men treated with officebased, outpatient Rez um for BPH, baseline MSHQ function and bother score, along with median IIEF predicted preservation or decline in sexual function after 12 and 24 months.